EPA Works to Reduce Air Pollution in 32 States by Improving Older School Buses

Today, the U.S. Environmental Protection Agency (EPA) awarded more than $8.7 million to replace or retrofit 452 older diesel school buses. The funds are going to 141 school bus fleets in 32 states, each of which will receive rebates through EPA's Diesel Emissions Reduction Act (DERA) funding. The new and retrofitted buses will reduce pollutants that are linked to health problems such as asthma and lung damage.

AAFA Joins Other Patient Groups to Voice Concerns Over Health Care Ruling

Access to proper health care coverage is essential and life-saving for people with asthma and allergies. The Asthma and Allergy Foundation of America has joined other patient groups to make up the I Am Essential coalition to advocate against changes that could threaten health care coverage for those we serve. This press release outlines the coalition's concerns about these proposed changes.

FDA Warns of Fraudulent and Unapproved Flu Products

As part of the U.S. Food and Drug Administration’s ongoing efforts to protect consumers from health fraud, the agency is reminding consumers to be wary of unapproved products claiming to prevent, treat or cure influenza, or flu. This year’s severe flu season raises new concerns about the potential for consumers to be lured into buying unproven flu treatments, and even worse, buying counterfeit antivirals online from websites that appear to be legitimate online pharmacies.

AAFA Study Shows A Higher Burden of Disease for Patients with Adult- and Late Childhood-onset Atopic Dermatitis vs Patients with Early Childhood-onset Atopic Dermatitis

Asthma and Allergy Foundation of America Study Shows A Higher Burden of Disease for Patients with Adult- and Late Childhood-onset Atopic Dermatitis vs Patients with Early Childhood-onset Atopic Dermatitis WASHINGTON, D.C. (March 4, 2018) - The Asthma and Allergy Foundation of America (AAFA) today announced data demonstrating a higher burden of disease for patients with adult- and late childhood-onset atopic dermatitis (AD) vs patients with early childhood-onset AD. These results are from the...

Tree Pollen: Spring’s First Allergy Offender

When spring allergy season first starts, causing you to sniffle and sneeze, tree pollen is to blame. Trees start producing pollen as early as January in the Southern U.S. Many trees keep producing pollen through June. What Are the Symptoms of a Tree Pollen Allergy? Pollen allergy symptoms are commonly called “hay fever.” Pollen released by trees, as well as grasses and weeds, cause these symptoms. They include: Runny nose and mucus production Sneezing Itchy nose, eyes, ears and mouth Stuffy...

Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication

QVAR® RediHaler™ (beclomethasone dipropionate HFA) Inhalation Aerosol is now available to patients by prescription! It is the first and only breath-actuated inhaled corticosteroid for the maintenance treatment of asthma in patients ages 4 and older. QVAR® RediHaler™ is not used to relieve sudden breathing problems and won’t replace a rescue inhaler.

AAFA Issues Parental Guidance Warning About New Peter Rabbit Film

The Asthma and Allergy Foundation of America (AAFA) cautions parents raising children with food allergies that some scenes in the newly-released “Peter Rabbit” film may be disturbing for young viewers with food allergies. In the film, a character with a known food allergy to blackberries is attacked with them. This leads to a severe allergic reaction known as anaphylaxis and the need to use a lifesaving injection of the drug epinephrine.

Is It Really Asthma or Could It Be Something Else?

If you are on a treatment plan for asthma but the treatment doesn’t seem to be working, you might not have asthma. Or you may need a different type of asthma medicine. If you’ve been misdiagnosed, you might be trying to treat a condition you don’t have – and at the same time possibly ignoring a condition you really have.

Asthma and Allergy Foundation of America Appoints Kenneth Mendez as CEO

The Asthma and Allergy Foundation of America (AAFA) has appointed Kenneth Mendez as its president and chief executive officer, effective January 22, 2018. Mendez has built his career in senior leadership by successfully growing the reach of numerous non-profit organizations, a track record he now brings to AAFA in support of its mission to improve the health and quality of life for more than 60 million Americans with asthma and allergies.